FAQ: What are the proposed IOM recommendations for HIV Social Security Disability claims?
The Institute of Medicine is recommending to the Social Security Administration that Social Security Disability applicants with HIV be awarded benefits if they meet one of the following criteria:
1. A CD4 cell count at or below 50 cells per cubic milliliters of blood serum, a laboratory benchmark that indicates an advanced stage of illness.
2. One of the few rare but fairly severe disabling HIV associated conditions, such as pulmonary Kaposi-Sarcoma, certain lymphomas, dimension, or progressive multi-focal leukoencephalopathy (PML).
3. An HIV associated condition that appears in another section of the SSA’s full Listing of Impairments such as cardiovascular disease, chronic kidney disease and hepatitis.
4. An HIV associated condition that is not already included in other sections such as neuropathy, neurocognitive disorders and wasting syndromes.
If your claim for Social Security Disability benefits as a result of AIDS has been denied, contact HIV Social Security Disability attorneys Cavey and Barrett. 727-894-3188
If you would like more information about your rights regarding Social Security Disability Benefits, you can order our FREE book,"Your Rights to Social Security Disability Benefits" by submitting the form in the sidebar. We will send it out immediately along with other important information.
For more information about Social Security Disability Benefits, visit our law firm web site at CaveyLaw.com. If you would like to speak with one of our Social Security Disability Benefits attorneys about your case, feel free to call us anytime at (727) 897-9117 or simply submit our contact form and we will get back to you quickly.


Ahttp://www.ghi.com/yourhealth/encyclopedia/articles/thrombophlebitisbasics.html (November 21, 2010)
There is no doubt that the criteria used by the Social Security Administration to evaluate HIV related Social Security Disability claims is outdated. It should be overhauled to include new qualification based on CD4 cell counts and new criteria recommended by the Institute of Medicine (IOM) on September 13, 2010.
